A group of scientists has successfully created a drug called Provenge that is an untried medicine for the advanced stages of prostate cancer have got a nod from the esteemed FDA. The manufacturers of this medicine are Dendron has confirmed the news.
The president and CEO of Dendron announced in a conference that it is a ground making the discovery for the matured stages of prostate cancer and a testimony of hope and promise in the arena of cancer-the deadly disease.
It is an effective and enduring drug that has been created to incite the immune system and catalyzes in fighting against prostate cancer and it really does not react to anti-androgen remedy.
The FDA advisory panel had stated in the year 2007 that FDA must approve the drug but the matter was delayed as intricate details were being researched about the survival of the patients.
A medical examination was conducted amongst 512 men that were suffering from prostate cancer and were at matured stages. The cancerous cell had been spread in the human body and there was no reaction to anti-androgen treatment. The result of the study was crystal clear concluded that men who had consumed Provenge had better chances of survival than those that had consumed a placebo.
Dendron and the study
The company is planning to submit the effective and progressive results to the FDA in the last quarter of 2009 and a stipulated period of six months will be required by the FDA to examine it.
Gold has clearly mentioned that this wonder drug has few side-effects like a cough, cold, fever, nausea, headaches, dizziness and fatigue along with a day or two of infusion. He states that all the men that have undergone surgery and later anti-androgen therapy because of the re-appearing of the nasty disease the levels of PSA rises post that. The drug is a beneficiary means of treating the disease. PSA (prostate-specific androgen) rankings are the best way of determining the success or failure of the cure of the disease.
Additional information about the drug
The company is not furnishing any more information or details about the conducted study. Everyone would be waiting with bated breath for the announcement that would happen in April at the American Urological Association’s yearly conference at Chicago. Gold has stated that state-of-art technology has been used to create the wonder drug and the same pattern may be useful for creating other medicines relating to cancer.
Response of American Cancer Society
Otis Brawley MD, chief medical officer at the American Cancer Society has stated it there is a good reason for everyone to be hopeful and cheerful about the scientific discovery that may facilitate in curing the lethal disease. Chance of survival is an important yardstick to measure the success of the disease. As it is a new and a virgin drug all the details would be examined before it is used on patients so that no mishap occurs.